Tc 99m depreotide

Drug Profile

Tc 99m depreotide

Alternative Names: Depreotide trifluoroacetate; NeoSpect; NeoTect; P 829; Tc 99m P 829

Latest Information Update: 15 Jun 2015

Price : $50

At a glance

  • Originator Bayer HealthCare Pharmaceuticals
  • Class Organotechnetium compounds; Radiopharmaceuticals; Small molecules; Technetium compounds
  • Mechanism of Action Image enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Market Withdrawal Lung cancer

Most Recent Events

  • 15 Jun 2015 Withdrawn for Lung cancer (Diagnosis) in Middle East (IV) before June 2015
  • 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
  • 29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top